Literature DB >> 16673611

Recommendations for antibiotic prophylaxis before ERCP: can we come to workable conclusions after review of the literature?

C Ceyssens1, J M E Frans, P S M Christiaens, W Van Steenbergen, W E Peetermans.   

Abstract

Infectious complications after endoscopic retrograde cholangiopancreatography (ERCP) are rare and can mainly be divided into endocarditis and sepsis/cholangitis. There still remains uncertainty about the indications, antibiotic regimens, and timing for antibiotic prophylaxis. Several guidelines for antibiotic prophylaxis have been published. It is the purpose of the present paper to make an extensive review of the literature and to yield general recommendations on antibiotic prophylaxis before ERCP. Antibiotic prophylaxis is recommended for patients at high risk for endocarditis, as well as for patients with a vascular graft less than 1 year old. For sepsis/cholangitis, prophylaxis is mostly recommended for patients with a bile duct obstruction or with a pancreatic pseudocyst. For other conditions, a case-by-case evaluation by the physician/endoscopist is still inevitable.

Entities:  

Mesh:

Year:  2006        PMID: 16673611     DOI: 10.1179/acb.2006.003

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  3 in total

Review 1.  Gastrointestinal Endoscopy-Associated Infections: Update on an Emerging Issue.

Authors:  Anasua Deb; Abhilash Perisetti; Hemant Goyal; Mark M Aloysius; Sonali Sachdeva; Dushyant Dahiya; Neil Sharma; Nirav Thosani
Journal:  Dig Dis Sci       Date:  2022-03-09       Impact factor: 3.487

2.  Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study.

Authors:  Mingmei Du; Jijiang Suo; Bowei Liu; Yubin Xing; Liangan Chen; Yunxi Liu
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-29       Impact factor: 4.887

3.  Bacterobilia in pancreatic surgery-conclusions for perioperative antibiotic prophylaxis.

Authors:  Colin Markus Krüger; Ulrich Adam; Thomas Adam; Axel Kramer; Claus D Heidecke; Frank Makowiec; Hartwig Riediger
Journal:  World J Gastroenterol       Date:  2019-11-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.